Trastuzumab subcutáneo en el tratamiento del cáncer de mama HER2 positivo
Enrique Díaz-Cantón, Martha Vega
openalex +2 more sources
Cost-Utility Analysis of Trastuzumab in Treatment Of Metastatic Her2-Positive Breast Cancer in Vietnam [PDF]
TT Nguyen, Thuy Thi Nguyen
openalex +1 more source
373P Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase III JBCRG-M06/EMERALD study [PDF]
Norikazu Masuda +19 more
openalex +1 more source
DESENSITIZATION TO PERTUZUMAB/TRASTUZUMAB/HYALURONIDASE-ZZXF IN A PATIENT WITH HYMENOPTERA ANAPHYLAXIS [PDF]
V. Saldana-Fraire +4 more
openalex +1 more source
Vinflunina más trastuzumab en cáncer de vejiga Her2 positivo previamente tratado: reporte de un caso
Samuel Rivera +1 more
openalex +1 more source
Life-Saving Reduced Dose of Trastuzumab-Deruxtecan in Metastatic HER2-Low Metastatic Breast Cancer with Major Hepatic Insufficiency: A Case Report [PDF]
Nahed Damaj +12 more
openalex +1 more source
Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab [PDF]
John T. Butterfield +4 more
openalex +1 more source
Socioeconomic disparities in long-term heart failure risk of trastuzumab with or without anthracyclines in early-stage breast cancer: a SEER-Medicare database analysis [PDF]
Karissa Britten +8 more
openalex +1 more source

